Revenue Comparison
Chart: Revenue Comparison. Values in USD_BILLIONS. In Q2 2026: Vertex Pharmaceuticals 3.334, Abbott Laboratories 12.593.
Vertex Pharmaceuticals vs Abbott Laboratories: Revenue Comparison
Vertex Pharmaceuticals (VRTX) and Abbott Laboratories (ABT) are peers in Healthcare. Vertex Pharmaceuticals reported revenue of $3.3B as of Q2 2026, compared with $12.6B for Abbott Laboratories. Abbott Laboratories leads on revenue.
Vertex Pharmaceuticals's gross margin is 85.3% versus 58.0% for Abbott Laboratories. Vertex Pharmaceuticals's net margin is 33.0% versus 7.4% for Abbott Laboratories.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, Vertex Pharmaceuticals, Abbott Laboratories.| Metric | Vertex Pharmaceuticals | Abbott Laboratories |
|---|---|---|
| Market Cap | - | - |
| Revenue | $3.33B | $12.59B |
| Cost of Revenue | $489.00M | $5.29B |
| Gross Profit | $2.85B | $7.30B |
| Operating Income | $1.25B | $1.78B |
| Net Income | $1.10B | $928.00M |
| R&D Expense | $994.00M | $882.00M |
| Earnings Per Share | $4.31 | $0.53 |
| Gross Margin | 85.3% | 58.0% |
| Operating Margin | 37.4% | 14.2% |
| Net Profit Margin | 33.0% | 7.4% |
| Free Cash Flow | $1.01B | $2.89B |
| Cumulative Free Cash Flow | $17.24B | $142.48B |
| Operating Cash Flow | $1.13B | $2.49B |
| Cash & Equivalents | $6.14B | $5.10B |